The correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosis

Hepato-Gastroenterology

Volumn 60, Issue 123, 2013, Pages 553-556

  Chen, Li Tian ^a   Lin, Li Juan ^b   Zheng, Lin Lin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b EASTERN LIAONING UNIVERSITY   (China)

Author keywords

Carcinoma; Hepatocyte; Insulin like growth factor II mRNA binding protein 3; Prognosis

Indexed keywords

KI 67 ANTIGEN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; RNA-BINDING PROTEINS; TIME FACTORS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 84879585978     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12855     Document Type: Article

References (26)

1. Jiao J, Hong S, Zhang J, et al.: Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway. Cancer Lett 2012; 320(1):96-103.
2. Yang Y, Liu YM, Wei MY, et al.: The liver tissue bank and clinical database in China. Front Med China 2010; 4(4):443-447.
3. Bi MP, Yang DH, Li XH, et al.: Association of cellular inhibition of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 2012;32(7):1020-1025,1030. (Article in Chinese)
4. Han YF, Zhao J, Ma LY, et al.: Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol 2011; 17 (38):4258-4270.
5. Jin L, Seys AR, Zhang S, et al.: Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study. Diagn Mol Pathol 2010; 19(2):63-69.
6. Noske A, Faggad A, Wirtz R, et al.: IMP3 expression in human ovarian cancer is associated with improved survival. Int J Gynecol Pathol 2009; 28(3):203-210.
7. Rink M, Chun FK, Robinson B, et al.: Tissue-based molecular markers for renal cell carcinoma. Minerva Urol Nefrol 2011; 63(4):293-308.
8. Wachter DL, Schlabrakowski A, Hoegel J, et al.: Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma. Am J Surg Pathol 2011; 35(6):873-877.
9. Schaeffer DF, Owen DR, Lim HJ, et al.: Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC Cancer 2010; 23; 10:59.
10. Wang L, Li HG, Xia ZS, et al.: IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study. Chin Med J (Engl) 2010; 123(24):3554-3558.
11. Köbel M, Xu H, Bourne PA, et al.: IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol 2009; 22(3):469-475.
12. Li D, Yan D, Tang H, et al.: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol 2009; 16(12):3499-3506.
13. Vranic S, Gurjeva O, Frkovic-Grazio S, et al.: IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast. Appl Immunohistochem Mol Morphol 2011; 19(5):413-416.
14. Sidoni A, Cartaginese F: IMP3 expression in triple-negative breast carcinoma. Hum Pathol 2010; 41(9):1355-1356.
15. Köbel M, Weichert W, Crüwell K, et al.: Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch 2004; 445(5):456-464. (Pubitemid 39592748)
16. Müeller-Pillasch F, Lacher U, Wallrapp C, et al.: Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997; 14(22):2729-2733. (Pubitemid 27283112)
17. King R, Pasha T, Roullet MR, et al.: IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue. Hum Pathol 2009; 40(12):1699-1705. (PMID: 19698973)
18. Pryor JG, Bourne PA, Yang Q, et al.: IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol 2008; 21(4):431-437. (Pubitemid 351441031)
19. Yu L, Xu H, Wasco MJ, et al.: IMP-3 expression in melanocytic lesions. J Cutan Pathol 2010; 37(3):316-322.
20. Liao B, Hu Y, Brewer G: RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem 2011; 286(36):31145-31152.
21. Gredes T, Spassov A, Mai R, et al.: Changes in insulin like growth factors, myostatin and vascular endothelial growth factor in rat musculus latissimus dorsi by poly-3-hydroxybutyrate implants. J Physiol Pharmacol 2009; 60(3):77-81.
22. Özkalay Özdemir N, Şen Türk N, Düzcan E: IMP3 expression in urothelial carcinomas of the urinary bladder. Türk Patoloji Derg 2011; 27(1):31-37.
23. Liao B, Hu Y, Herrick DJ, et al.: The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 2005; 280(18):18517-18524. (Pubitemid 41389102)
24. Vikesaa J, Hansen TV, Jønson L, et al.: RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 2006; 25(7):1456-1468.
25. Alam S, Bowser BS, Conway MJ, et al.: Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells. Mol Cancer 2011; 10:97-120.
26. Freudlsperger C, Freier K, Hoffmann J, et al.: Ki-67 expression predicts radiosensitivity in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2012; 41(8):965-969.